Chemoprevention of Gastric Carcinogenesis

ABSTRACT: A clinical study of the efficacy of oral alpha-difluoromethylornithine (eflornithine or DFMO) in male and female subjects ages 30-60 with gastric premalignant lesions in two high risk regions of Latin America.

DISEASE(S): Metaplasia,Gastric Intestinal Metaplasia,Gastric Cancer,Carcinogenesis

PROVIDER: 2216849 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR